NEW YORK (AP) _ Royalty Pharma (RPRX) on Wednesday reported third-quarter profit of $102 million.

The New York-based company said it had profit of 17 cents per share. Earnings, adjusted for non-recurring costs, were 73 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 69 cents per share.

The company posted revenue of $586 million in the period. Its adjusted revenue was $587 million.

Royalty Pharma expects full-year revenue in the range of $2.11 billion to $2.13 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News